Company / Operating Income
Bicara Therapeutics Inc. Operating Income History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$82.4M
FY2024
5-year range
-$82.4M / -$39.9M
FY2023-FY2024
Trend
-106.5%
vs FY2023
Sector context
#83 of 204
Health Care
What the data says
At -$82M, Bicara Therapeutics Inc.'s operating income ranks #83 of 204 in the Health Care sector.
Based on SEC 10-K filings.
-$82M in FY2024.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 204 in Health CareTop 41% of 204This company -$82.4M Sector average $107.8M
▼
-176.5% below sector average
Key checks
Key Insights
- In FY2024, operating income decreased 106.5% year-over-year.
- Ranks #83 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 11.58 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$82.4M | -106.5% |
| FY2023 | -$39.9M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026